Immunohistochemistry (IHC) is a special test to detect specific antigens (polypeptides, proteins) at tissue sites. In the field of biology, it is a very powerful tool for pathologists, using both monoclonal and polyclonal antibodies to determine the distribution of tissue antigens in samples for health and disease.
IHC plays an important role in pathology and also has many uses in medicine, especially in diagnosing cancer, such as diagnosing lymphoma. To know more about ihc service visit https://www.bosterbio.com/services/assay-services/ihc-histology-services.
In the IHC method, detection of this antigen is achieved using antibodies that specifically bind to this antigen in biological tissue, which has clear advantages over the specialized enzyme staining techniques commonly used. Therefore, IHC technology is a key tool for medical research, clinical diagnosis, drug development, and biological research.
Regarding the application of cancer diagnosis, the IHC technique is used by doctors to diagnose cancer along with the use of certain tumour markers. This helps the doctor determine whether the cancer is benign or malignant, as well as the stage and grade, cell type, and origin of the metastases, which can help determine the primary tumor.
IHC is also used to predict therapeutic response, diagnose unsafe tumors, determine infectious agents in tissues, and the like. For drug development, IHC is used to track activity and adjust the target disease up or down to test the effectiveness of the drug.